Medical embedded systems design for connected and regulated devices
Medical embedded systems are no longer just device controllers
Medical embedded systems are purpose-built computing platforms inside devices used for diagnosis, monitoring, therapy or clinical workflow support. They sense, process, decide, communicate and control while meeting safety, performance and regulatory expectations. The design challenge has changed because many devices are no longer isolated instruments. They may connect to hospital networks, transmit data to cloud services, receive security updates, run AI-enabled functions or support home-care use.
That shift makes the embedded platform part of the total product lifecycle, not just a one-time hardware design. For engineering teams, the practical work is to align system architecture, risk management, software lifecycle controls, cybersecurity and postmarket maintenance from the start.
For readers following embedded systems, the medical sector shows how embedded design changes when failure modes can affect patient safety, clinical decisions and regulatory approval.
What counts as a medical embedded system
A medical embedded system is not defined only by its microcontroller, processor or operating system. It is defined by the intended medical function of the device in which the computing system operates. A temperature sensor in a consumer product and a temperature sensor in an infusion pump may use similar electronics, but the infusion pump requires stronger design controls, traceability, alarm behavior, verification and documentation because incorrect behavior may create clinical risk.
Common examples include patient monitors, infusion pumps, ventilators, implantable devices, imaging equipment, wearable diagnostic devices, connected glucose meters, robotic surgical subsystems and home-care therapeutic devices. Some systems run on small microcontrollers with bare-metal firmware. Others use real-time operating systems, Linux-based gateways, wireless modules, secure elements, AI accelerators and cloud-connected companion applications.
It is also useful to separate embedded medical software from software as a medical device. The International Medical Device Regulators Forum describes software as a medical device as software intended for medical purposes without being part of a hardware medical device. Embedded software, by contrast, is part of a physical product such as a monitor, pump or scanner. In practice, product teams increasingly manage both categories together because connected hardware, mobile apps and cloud analytics may share data, hazards and cybersecurity responsibilities.
The core architecture decisions
Medical embedded systems usually start with architecture decisions that shape the whole product lifecycle. The first is the safety role of the embedded function. Software that logs noncritical data does not need the same controls as software that closes a therapy loop, triggers an alarm or modifies treatment delivery. A risk-based architecture helps teams decide where redundancy, watchdogs, self-tests, alarm priorities and independent protection mechanisms are needed.
The second question is timing. Many medical devices require deterministic behavior. A real-time operating system may be appropriate when tasks must be scheduled predictably, while a richer operating system may be useful for user interfaces, imaging pipelines or connectivity. Hybrid designs often separate safety-critical control from user-facing or network-facing functions. For example, a low-level controller may manage actuation and sensing, while a higher-level processor handles display, logging, wireless communication or analytics.
The third question is data integrity. Medical data often moves through sensors, analog front ends, digital filters, embedded algorithms, local storage, network protocols and external systems. Each step can introduce latency, truncation, calibration drift, synchronization errors or corrupted records. Good design treats data flow as an engineering object, not an implementation detail. Time stamps, calibration metadata, audit trails, error detection and version control can become as important as the sensor itself.
The fourth question is power and operating environment. Wearables, implantables and home-care devices face battery constraints, body-worn comfort requirements, cleaning and disinfection exposure, wireless coexistence issues and intermittent connectivity. Hospital equipment may face electromagnetic compatibility, serviceability and integration with clinical IT. These constraints should be visible in requirements instead of appearing late during verification.
Regulatory and standards pressure is moving earlier in design
Medical embedded systems are designed within quality, risk and software lifecycle expectations. In the United States, the FDA Quality Management System Regulation became effective on February 2, 2026, and incorporates ISO 13485:2016 by reference as the foundation for medical device quality management systems. This matters for embedded teams because design outputs, risk controls, purchasing controls, production processes and service activities all connect back to the quality system.
Risk management is another central thread. ISO 14971:2019 provides a widely used framework for identifying hazards, estimating and evaluating risk, implementing controls and monitoring control effectiveness throughout the device lifecycle. For embedded systems, software, electronics, sensors, usability, data security, power failure, alarms and maintenance are not separate checklists. They are related sources of risk that should be evaluated together.
Software lifecycle expectations are commonly mapped to IEC 62304, which defines lifecycle processes for medical device software and remains current after review in 2023. FDA’s June 14, 2023 guidance on the content of premarket submissions for device software functions also highlights the need for software documentation that is appropriate to risk. For engineering teams, the implication is direct: architecture, requirements, risk controls, verification, configuration management and unresolved anomalies need to be organized as evidence, not reconstructed at the end of development.
| Area | Why it matters for embedded teams | Common reference point |
|---|---|---|
| Quality management | Connects design controls, supplier controls, production and corrective action | FDA QMSR and ISO 13485:2016 |
| Risk management | Links hazards, foreseeable misuse, security issues and control effectiveness | ISO 14971:2019 |
| Software lifecycle | Defines disciplined development and maintenance processes for medical software | IEC 62304 |
| Cybersecurity lifecycle | Builds security activities into development and maintenance of health software | IEC 81001-5-1:2021 and FDA cybersecurity guidance |
| AI change control | Helps manage planned modifications to AI-enabled device software functions | FDA PCCP guidance issued in August 2025 |
Cybersecurity is now a product safety issue
Connectivity has changed the risk profile of medical embedded systems. A device that connects to the internet, hospital infrastructure, a companion app or a cloud service may expose attack surfaces that did not exist in older stand-alone instruments. The safety concern is not limited to privacy. A cyber weakness could affect availability, data integrity, alarm behavior, therapy delivery or the ability to deploy urgent patches.
FDA’s February 2026 cybersecurity guidance addresses cybersecurity device design, labeling and premarket submission documentation for devices with cybersecurity risk. FDA also explains that section 524B of the Federal Food, Drug, and Cosmetic Act applies to certain cyber devices in premarket submissions. Its public FAQ describes a cyber device as one that includes validated or authorized software, can connect to the internet and includes technological characteristics that could be vulnerable to cybersecurity threats. The same FAQ states that the cybersecurity requirements apply to relevant submissions starting March 29, 2023, and that beginning October 1, 2023, FDA expected sponsors to have had sufficient time to prepare submissions containing the required information.
For embedded design, cybersecurity has to be engineered into the product lifecycle. Practical controls may include secure boot, signed firmware, vulnerability monitoring, software bill of materials practices, least-privilege access, encrypted communications, authenticated updates, logging, coordinated vulnerability disclosure and tested recovery behavior. These controls should be connected to risk analysis. A generic security feature list is weaker than a documented argument showing which hazards and misuse scenarios each control reduces. See also: BUYING GUIDES.
IEC 81001-5-1:2021 is also relevant because it defines lifecycle requirements for secure health software development and maintenance. It emphasizes a balance of safety, effectiveness and security. That balance is critical in medical embedded systems because a security update that interrupts clinical workflow, breaks alarm behavior or changes validated timing can create new risk even if it closes a vulnerability.
AI and connectivity are changing the update model
AI-enabled functions are becoming more common in medical devices, especially where devices interpret images, waveforms, sensor signals or patient trends. FDA reported that it had authorized more than 1,600 AI-enabled medical devices for marketing in the United States as of September 2026. That number does not mean every embedded device needs AI. It does show that algorithms are becoming part of regulated device design and that embedded platforms may need to support more complex inference, data governance and update strategies.
AI changes the embedded design conversation in three ways. First, the system must manage model inputs. If sensor quality, calibration, patient population, lighting, motion artifacts or signal preprocessing change, algorithm performance can change. Second, the system must manage model outputs. An AI recommendation may affect clinical decisions, alarms or therapy adjustments, so user interface design and human factors remain central. Third, the system must manage model updates. A model that improves over time still needs controlled validation and change management.
FDA’s August 2025 final guidance on predetermined change control plans for AI-enabled device software functions describes how a marketing submission may include planned modifications, the methodology to develop, validate and implement those modifications, and an assessment of their impact. For embedded teams, this moves planning earlier. If a device may need model updates after release, hardware capacity, software partitioning, logging, rollback behavior, cybersecurity controls and verification strategy should be designed before launch.
A practical design checklist for engineering teams
The following checklist is not a substitute for regulatory or quality-system work. It summarizes engineering questions that often determine whether a medical embedded system is maintainable, verifiable and resilient.
- Define the medical function clearly. Separate wellness, administrative, monitoring, diagnostic and therapeutic claims because intended use drives the risk profile.
- Map hazards to architecture. Connect each significant hazard to prevention, detection, mitigation or recovery behavior in hardware and software.
- Separate safety-critical functions where practical. Isolate control loops, alarms or therapy functions from network-facing or user-interface components when the risk analysis supports it.
- Design for verification from day one. Requirements should be testable, traceable and linked to risk controls, not written as broad design aspirations.
- Control third-party components. Wireless modules, operating systems, libraries, sensors and AI frameworks can create supply-chain, security and maintenance obligations.
- Plan updates and rollback behavior. A safe update process includes authentication, compatibility checks, failure recovery and a clear decision about what happens during clinical use.
- Document unresolved anomalies. Bugs that remain in released software should be assessed for safety impact and controlled through the quality system.
- Think beyond launch. Service, calibration, vulnerability monitoring, complaint handling and field performance data can reveal new risks after deployment.
One useful engineering habit is to maintain a living system model that includes hardware blocks, software items, data flows, trust boundaries, user interactions and risk controls. This model can support architecture reviews, threat modeling, verification planning and regulatory documentation. It also helps avoid a common failure mode: treating cybersecurity, software validation and risk management as separate projects instead of connected evidence about the same product.
Where medical embedded systems are heading
The direction is clear. Medical embedded systems are becoming more connected, more software-defined and more dependent on lifecycle evidence. More care is moving into homes and ambulatory settings, which increases the need for reliable wireless behavior, battery management, remote monitoring and understandable user interfaces. At the same time, hospitals and regulators expect stronger cybersecurity, better update discipline and clearer software documentation.
There are limits to this trend. Not every device benefits from cloud connectivity, AI or a complex operating system. In safety-critical products, simpler architecture can be an advantage when it improves determinism, reduces attack surface and makes verification easier. The best design choice is not the newest processor or the largest software stack. It is the architecture that can meet clinical needs, manage risk, support maintenance and produce credible evidence over the product lifecycle.
For 2026 and beyond, the most competitive medical embedded systems will likely be those that combine conservative safety engineering with modern security and data practices. The engineering value is not only in making the device function. It is in proving, maintaining and updating that function responsibly in the environments where patients and clinicians actually use it.
Frequently asked questions
How are medical embedded systems different from ordinary embedded systems?
They may use similar processors, sensors and firmware techniques, but the intended medical use creates additional requirements for risk management, traceability, verification, cybersecurity, usability and quality-system control. A failure that is acceptable in a consumer device may be unacceptable in a clinical device.
Does every connected medical device need the same cybersecurity controls?
No. Controls should be risk based. A device that can affect therapy delivery, alarms or clinical data integrity needs a stronger security argument than a device with limited connectivity and no safety impact. However, any internet-connectable device with validated or authorized software should be evaluated carefully against current cybersecurity expectations.
Is IEC 62304 only for software-only medical products?
No. IEC 62304 is relevant to medical device software, including embedded software inside hardware devices. It is commonly used to organize software development and maintenance processes, especially where software behavior affects safety or performance.
Why does AI make embedded medical design harder?
AI introduces dependencies on data quality, model validation, performance monitoring and controlled updates. If the model is updated after release, the device may also need architecture support for secure deployment, rollback, logging and evidence that the change does not create unacceptable risk.
